} ?>
On March 24, Kechuang Pharmaceutical ETF (588860) closed down 0.98%, with a turnover of 32.7082 million yuan.
Sci-Tech Pharmaceutical ETF (588860) was established on August 8, 2024, and the full name of the fund is ICBC Credit Suisse SSE Science and Technology Innovation Board Biomedical Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as Kechuang Pharmaceutical ETF. The fund has a management fee of 0.45% per annum and a custody fee of 0.07% per annum. The performance of the STAR Pharmaceutical ETF (588860) is based on the return rate of the SSE STAR Market Biomedical Index.
In terms of scale, as of March 21, the latest share of Kechuang Pharmaceutical ETF (588860) was 354 million shares, and the latest scale was 433 million yuan. Looking back on December 31, 2024, the share of Kechuang Pharmaceutical ETF (588860) was 476 million, with a scale of 524 million yuan. That is, the share of the fund has decreased by 25.61% and the scale has decreased by 17.41% since the beginning of this year.
In terms of liquidity, as of March 24, the cumulative turnover of Kechuang Pharmaceutical ETF (588860) in the past 20 trading days was 948 million yuan, with an average daily turnover of 47.3887 million yuan.
The current fund manager of Kechuang Pharmaceutical ETF (588860) is Shi Baojun. Shi Baojun has managed (or intends to manage) the fund since August 8, 2024, with a return of 22.11% during his tenure.
According to the latest regular report, the heavy stocks of Kechuang Pharmaceutical ETF (588860) include United Imaging Medical, Huitai Medical, BeiGene, Baili Tianheng, Junshi Biosciences, Allist, Aibo Medical, Tebao Biotech, Zelgen Pharmaceutical, and Bloomage Biotech, with the following proportions.
stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
688271 | United Imaging Medical | 9.66%, | 400,650,639,900||
688617 | Huitai Medical | 6.36%, | 89,533,324,700||
688235 | BeiGene | 5.41% | 176,1028,351,600||
688506 | Baili Tianheng | 4.49% | 122,823,546,700||
688180 | Junshi Biosciences | 4.29%, | 822,822,487,600 | |
688578 | Allist | 3.95%, | 345,120,672,900 | |
688050 | Aibo Medical | 3.52% | 202,6018,445,900||
688278 | Tebao Biotech | 3.50% | 249,600 | 18,316,100 |
688266 | Zejing Pharmaceutical: | 3.38%, | 284,100 | ,7,703,800 |
688363 Bloomage | Biotech | 2.88%, | 295,315,074,600 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date